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Abstract
The use of a composite graft of bovine trabecular demineralized bone matrix (DBM) and perichondrium has been found a reliable
method for in vivo generation of cartilage. In the present study, the mechanism whereby this commercially available matrix increases
cartilage formation was investigated.
First, the time course of cartilage formation in vivo, in the combined implant of perichondrium and DBM in the rabbit ear was
studied, with special focus on tissue reactions to DBM. DBM was colonized by macrophages from day 3 post-operatively, reaching
a maximum after 2 weeks. Only a minimal number of neutrophils was found. After 3 weeks the DBM appeared to be resorbed. In the
Þrst week the DBM was invaded with chondroblasts, and chondrogenesis occurred between the Þrst and second week of implantation.
After 3 weeks, the initially formed islets of cartilage had fused.
Next, the chondrogenic capacity of DBM itself was investigated by implantation of DBM without perichondrium. This never
resulted in cartilage formation. Immunohistochemistry showed only a faint staining of the DBM for growth factors. This indicates
a minimal chondrogenic e⁄ect of DBM alone and the requirement of perichondrium as cell provider.
In order to deÞne the conditions which cause chondrogenesis in composites of perichondrium and DBM, a series of in vitro culture
experiments was performed in which the in vivo situation was mimicked step by step. The basic condition was perichondrium cultured
in medium with 10% FCS. In this condition, cartilage formation was variable. Because in the in vivo situation both DBM and
macrophages can release growth factors, the e⁄ect of IGF1, TGFb2 or OP1 added to the culture medium was tested. Neither the
incidence nor the amount of cartilage formation was stimulated by addition of growth factors. Perichondrium wrapped around DBM
in vitro gave cartilage formation in the perichondrium but the incidence and amount were not signiÞcantly stimulated compared to
cultures of perichondrium without DBM. However, cartilage-like cells were found in the DBM suggesting an e⁄ect of DBM on
perichondrium-derived cells. Finally, macrophages and/or blood were added to the composite DBM-perichondrium to mimic the in
vivo situation as close as possible. However, no e⁄ect of this treatment was found.
In conclusion, this study indicates that DBM itself has few chondrogenic qualities but functions merely as a spacer for cell ingrowth.
The fast resorption of DBM by macrophages in vivo seems of importance for the cartilage forming process, but in vitro the presence of
macrophages (in combination with blood) could not enhance chondrogenesis. ( 1999 Elsevier Science Ltd. All rights reserved
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1. Introduction
Defects in the cartilage of nose, cricoid, ear or articular
joints show limited tendency of spontaneous healing. For
repair of these defects with transplants, the use of
*Corresponding author. Tel.:#31 10 4087661; fax:#31 10 4367146.
autologous tissue is preferred in order to avoid immuno-
logical reactions and the risk of transmittable diseases.
The amount of autologous cartilage that can be har-
vested is limited and the consequent donor site morbidity
is high. In contrast, isolation of autologous perichon-
drium is relatively easy for patient and surgeon and
results in minimal donor site morbidity and a low com-
plication rate. Therefore, perichondrium has been
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suggested as a producer of new cartilage [1—5]. The
amount of cartilage generated from perichondrium in
vivo, however, appeared to be variable and unpredictable
[1—3]. In previous research, our group has demonstrated
a new experimental method using rabbits: a composite
graft of trabecular demineralized bone matrix (DBM)
and perichondrium can provide much more consistent
results [6, 7]. Perichondrium wrapped around DBM
leads to gradual replacement of the DBM by autologous
cartilage tissue [6] even in the child [8]. Implanted
subcutaneously in the ear or intramuscularly in the quad-
riceps of rabbits the grafts showed cartilage formation in
100% of the samples after 3—6 weeks [7].
In our studies a trabecular matrix (DBM, Osteovit’)
was chosen because the porosity of the matrix was con-
sidered of importance for the ingrowth of cells. The role
of DBM for chondrogenesis could be ÔphysicalÕ, by acting
as a spacer for cell ingrowth or ÔchemicalÕ, induced by
growth factors which are suggested to be present in the
matrix. The aim of this study was to investigate the role
of the trabecular DBM in this process in more detail. We
Þrst studied the time course of the cartilage generating
process in vivo with special focus on cellular responses to
DBM. The chondrogenic capacities of the material itself
were evaluated by implantation of the material without
perichondrium. In the literature, cortical DBM is often
described to induce chondro- and osteogenesis and is
demonstrated to contain growth factors [9, 10]. We
studied the presence of growth factors in our matrix
using immunohistochemistry. Since TGFb, BMP and
IGF are recognized as factors present in DBM [9, 10]
and are described to induce chondrogenesis [11—15],
they were added to perichondrium in culture to study the
e⁄ects on chondrogenesis. In a further attempt to deÞne
the conditions that permit chondrogenesis in the com-
posite of perichondrium and DBM, we mimicked the
in vivo procedure in culture. Perichondrium was wrap-
ped around DBM and cultured in vitro and the e⁄ects of
addition of macrophages and blood was evaluated on
histology.
2. Materials and methods
The various experimental conditions are outlined in
Table 1.
2.1. In vivo studies
Twelve female New Zealand White rabbits were used
(weighing 1200—1800 g, age 6—12 weeks). Anaesthesia was
given with xylazine-hydrochloride (Rompun, Bayer,
Leverkusen, Germany) 10 mgkg~1 body weight and
ketamine-hydrochloride (Ketalin, Apharma, Arnhem,
Netherlands) 50 mgkg~1 body weight via intramuscular
injection.
Table 1
Overview of all experimental conditions tested in vivo and in vitro with
time of harvesting (time) and sample size (n)
Experimental conditions Time n
(a) In vivo experiments with DBM
DBM with perichondrium d3 6
wk1 6
wk2 6
wk3 6
DBM without perichondrium wk1 6
wk2 6
wk3 6
(b) In vitro experiments of perichondrium with growth factors
Perichondrium#FCS wk3 66
Perichondrium#FCS#TGFb wk3 17
Perichondrium#FCS#OP1 wk3 16
Perichondrium#FCS#IGF1 wk3 15
Perichondrium!FCS#IGF1#TGFb2 wk3 15
(c) In vitro experiments of perichondrium with DBM, cultured
in 10% FCS
Perichondrium!DBM wk3 66
Perichondrium#DBM wk3 47
Perichondrium#DBM#macrophages wk3 10
Perichondrium#DBM#blood wk3 14
Perichondrium#DBM#macrophages#blood wk3 10
Perichondrium#DBM colonized in vivo wk3 5
DBM colonized in vivo wk3 5
The operation site was shaved and disinfected with
70% ethanol. After making a rectangular incision (ap-
proximately 2]6 cm2) at the concave side of the ear, the
skin was elevated and the perichondrium dissected from
the underlying cartilage. A rectangular piece of trabecu-
lar DBM (Osteovit’, Braun Gmbh, Melsungen, Ger-
many) measuring approximately 4]4]8 mm3 was
soaked in blood. This block was wrapped in perichon-
drium such that the perichondrial side dissected o⁄ the
cartilage (the cambium layer) faced the DBM surface,
and left in situ in the ear for 3 days, 1, 2 or 3 weeks.
Furthermore, DBM was implanted subcutaneously with-
out perichondrial envelope and left in the ear for 1, 3 or
6 weeks.
2.2. In vitro studies
Ear perichondrium was obtained from 15 young fe-
male New Zealand White rabbits (age 6—12 weeks) as
described above. After washing with physiological saline
containing gentamicin (50 lgml~1) and fungizone
(0.5 lgml~1) to remove blood and contaminants, the
perichondrium was cut into pieces of about 2 mm2 using
scalpels. Four explants were cultured per well of a 24-
wells plate in DMEM/HamÕs F12 (1 : 1) medium (Life
Technologies, Breda, The Netherlands) containing 10%
heat-inactivated FCS, 25 lgml~1 L-ascorbic acid (Sigma),
50 lgml~1 gentamicin and 0.5 lgml~1 fungizone. The
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explants were cultured for 3 weeks and medium was
changed three times per week. Results were evaluated
using histological analysis.
The in vitro studies attempted to mimic step by step
the in vivo situation (Fig. 1). As possible chondrogenic
factors, growth factors were added to cultures of
perichondrium or perichondrium was combined with
DBM. Addition of macrophages, important for resorp-
tion of the matrix in-vivo, was studied next. Finally,
DBM was ÔcolonizedÕ by cells in vivo before it was en-
wrapped with perichondrium and subsequently cultured
in vitro.
To test the e⁄ects of growth factors, rhTGF-b2
(Sandoz, Switzerland), rhOP-1 (Creative Biomolecules,
Hopkinton, Massachusetts) or rhIGF-1 (Boehringer-
Mannheim, Almere, The Netherlands) were added to ear
perichondrium cultured in medium with 10% FCS.
TGF-b2 and OP-1 were added in a concentration of
10 ngml~1 continuously or as a pulse treatment in a con-
centration of 100 ng ml~1 for the Þrst 2 days only. IGF-1
was added in a concentration of 10 ng ml~1 continuous-
ly. Furthermore, the e⁄ect of a combination of
10 ngml~1 IGF-1 and 10 ngml~1 TGF-b2 added for
3 weeks was tested under serum-free conditions in
DMEM/HamÕs F12 medium with 0.1% BSA and
25 lgml~1 L-ascorbic acid. All concentrations were
based on data from literature [11—17].
DBM was cut into pieces of 2—6 mm3 and a combina-
tion of DBM and perichondrium were tested under the
following conditions:
(1) Perichondrium explants excised at a size of approx-
imately 2]7 mm and wrapped around the DBM
matrix, with the layer which faced the cartilage to-
wards the DBM, and cultured for 3 weeks.
(2) DBM seeded with macrophages before peri-
chondrium was wrapped around it. Autologous
macrophages were isolated together with the
perichondrium by washing the peritoneal cavity of
the rabbit with PBS immediately after killing the
animal. The peritoneal cavity was opened with
a small incision and 0.3—0.5 l PBS was introduced in
the cavity. After closing the incision, the abdomen
was gently massaged to allow solvation of peritoneal
macrophages in PBS. Then, as much PBS (with cells)
as possible was retained from the cavity through
a disposable needle (1.1 mm]40 mm). The cells were
separated from the solution by centrifugation. Cyto-
spins stained with mAb CD68 showed that’95% of
the isolated cells were macrophages. After washing,
the cells were seeded in DBM in a density of
5]107 cellsml~1 to allow a large amount of macro-
phages to adhere to and degrade the DBM. After
incubation for at least 30 min, the DBM-macro-
phage composite was enwrapped in perichondrium.
(3) DBM (with or without macrophages) soaked in
autologous blood and cultured in vitro.
Fig. 1. Experimental design of in vitro conditions to mimic step by step
the in vivo situation.
(4) DBM pre-incubated in vivo by implantation of
10]10]3 mm DBM subcutaneously in the ear for
6 days. After harvesting, the DBM was cultured with
or without perichondrial envelope.
2.3. Histology
2.3.1. Presence of growth factors in DBM
Cryosections of pure DBM were prepared. Sections of
human demineralized bone were used as control. To
evaluate the e⁄ectiveness of the demineralization proce-
dure, staining according to Goldner was used. Immuno-
histochemical staining for growth factors IGF1 (using
a rabbit polyclonal, GroPep, Adelaide, Australia),
TGFb2 and 3 (using rabbit polyclonals 1 : 50, Santa Cruz
Biotechnology, CA) was performed after formalin Þx-
ation in the absence and presence of saponin. A signal
was made visible using 3-amino-9-ethylcarbazole (AEC)
as substrate.
2.3.2. In vivo cartilage formation
To study the chondrogenic potential of DBM, im-
plants without perichondrium were harvested after 1,
3 or 6 weeks. Implants with perichondrium were har-
vested after 3 days, 1, 2 and 3 weeks (n"6 for each time
point) to assess chondrogenesis and cellular response to
DBM. All specimens were cut into two equal parts; one
part was Þxed in 4% phosphate-bu⁄ered formalin, decal-
ciÞed with 10% EDTA and embedded in paraƒn. Serial
sections were cut (7 lm) and stained with Alcian Blue
8GX (Sigma, St Louis, MO) to study cartilage matrix
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formation. The other part was frozen in liquid nitrogen
and stored at !80¡C until cryosections (6 lm) were
made. Immunohistochemistry was performed on these
sections to characterize the matrix generated and to
evaluate the cell-mediated resorption of DBM. Sections
were Þxed in acetone. For collagen staining the sections
were treated with hyaluronidase (Sigma, St Louis, MO),
for chondroitin sulfate staining the sections were treated
with chondroitinase ABC (Sigma). The sections were
incubated overnight at 4¡C with mAb against collagen
type II (CIICI; 1 : 100; Developmental Studies Hybrido-
ma Bank), pro-collagen type I (M38; 1 : 1000; Devel-
opmental Studies Hybridoma Bank) or chondroitin
6-sulfate (3B3; 1 : 1000; ICN Biomedicals, Costa Mesa,
CA). To study host tissue reactions against DBM, sec-
tions were incubated for 2 h at room temperature with
mAbs against macrophages using CD68 (1 : 50; Behring,
Marburg, Germany) and neutrophils using a-lactoferrine
(1 : 25; Pharmingen, San Diego, CA). After incubation
with primary antibodies, sections were treated with
goat-anti-mouse biotin, followed by streptavidin alkaline
phosphatase (Supersensitive, Biogenics, Clinipath,
Duiven, The Netherlands). Alkaline phosphatase activity
was demonstrated using a New Fuchsin substrate
(Chroma, Kongen, Germany). This resulted in a red
coloured signal. Endogenous alkaline phosphatase activ-
ity was inhibited with levamisol (Sigma). Sections were
counterstained with GillÕs haematoxylin and embedded
in gelatin—glycerin.
2.3.3. In vitro cartilage formation
After three weeks in vitro, the explants were harvested,
Þxed in 4% phosphate bu⁄ered formalin and embedded
in paraƒn. Sections of 6 lm thickness were cut and four
sections, spaced 60 lm apart, were mounted on one slide,
stained with Alcian Blue 8GX and counterstained with
Nuclear Fast Red.
The incidence of new cartilage formation in the ex-
plants was scored. A FisherÕs exact test was used for
statistical analysis. The percentage of the area stained
with Alcian Blue was quantiÞed using image analysis
using Videoplan software (Kontron, Zeiss, The Nether-
lands) using two high quality sections at least 200 lm
apart, for each sample. Since small pieces of cartilage
could be included when perichondrium was dissected
(accounting for up to 10% of the tissue area), distinction
was made between pre-existing and newly formed carti-
lage based on the intensity of Alcian Blue staining and
the morphology of the cells. The amount of newly formed
cartilage was expressed as a percentage of the total area
corrected for pre-existing cartilage and calculated as fol-
lows:
Area newly formed cartilage/
(Total area!Area pre-existing cartilage).
The median and range were calculated and Kruskall
Wallis one-way ANOVA and rank sum test were used for
statistical analysis. A P value(0.05 was considered sta-
tistically signiÞcant.
Finally, immunohistochemical stainings for collagen
type II was performed on the paraƒn sections. Sections
were pretreated with pronase type XIV (Sigma) to regain
antigenicity which was lost due to formalin Þxation, and
with hyaluronidase (Sigma) to obtain better antibody
penetration. Incubation with monoclonal antibody II-
II6B3 (Developmental Studies Hybridoma Bank) was
followed by incubation with a second antibody con-
jugated with alkaline phosphatase. Alkaline phosphatase
activity was demonstrated with a New Fuchsin substrate,
resulting in a red color.
3. Results
3.1. In vivo
3.1.1. DBM without perichondrium
Without perichondrial cover, no cartilage or bone was
ever formed subcutaneously in the DBM. After three
weeks, the DBM was completely resorbed in three out of
six samples. After 6 weeks complete resorption of DBM
had occurred in all samples.
3.1.2. DBM with perichondrium
Cartilage formation. Three and seven days after im-
plantation, no cartilage formation was present in the
DBM. The perichondrium stained positive for (pro)col-
lagen type I and chondroitin sulfate. In addition, the
inner layer of the perichondrium stained positive for
collagen type II. After 7 days, cells and loose Þbrous
tissue was found between the trabeculae of the DBM.
Many of the cells stained positive for chondroitin sulfate
and occasionally for (pro)collagen type I. After 2 weeks,
islets of cartilage were found in the pores of the DBM
(Fig. 2). These islets showed positive staining for Alcian
Blue, chondroitin sulfate and collagen type II. After
3 weeks the islets of cartilage had fused to a massive
cartilaginous structure (Fig. 3). Occasionally, cysts and
bloodvessels were found in the cartilage.
Resorption of DBM. After 3 days the perichondrium
was markedly thickened. Macrophages were present in
the perichondrium tissue and some had also invaded the
graft and were attached to DBM. The Þrst 2 weeks after
implantation, the number of macrophages in perichon-
drium as well as DBM gradually increased (Fig. 4). After
2 weeks, the DBM was fragmented and after 3 weeks no
signs of DBM were observed any more and the amount
of macrophages was strongly reduced. Some macro-
phages were still present where islets of cartilage were not
completely fused.
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Fig. 2. Cartilage formation in vivo in a composite graft of de-
mineralized bovine bone matrix and ear perichondrium after 2 weeks.
Alcian Blue staining, original magniÞcation 100].
Fig. 3. Cartilage formation in a composite graft of demineralized bo-
vine bone matrix and ear perichondrium, 3 weeks after implantation
in vivo. Alcian Blue staining, original magniÞcation 100].
Fig. 4. Macrophages invading the DBM after 14 days implantation in
the rabbit ear. Macrophages are stained immunohistochemically with
mAb CD68, sections are counterstained with haematoxylin. Note mac-
rophages are located between the trabeculae of the DBM but also
attached to the DBM. Original magniÞcation 200].
Only a few neutrophils could be detected during the
whole period.
3.2. In vitro
Both the incidence and the amount of cartilage formed
in cultures with 10% FCS (controls) of auricular
perichondrium appeared to be variable. Cartilage forma-
tion varied between none or a few chondrocytes to
a maximum of half of the explant area (Fig. 5). To
investigate the role of DBM in chondrogenesis in vivo,
the presence of growth factors in demineralized bovine
trabecular bone matrix was tested. Immunohistochemis-
try demonstrated a faint staining for IGF1 and TGFb2,
3. The absolute amounts could not be determined this
way, but staining was generally much lower than in
human trabecular bone which had been demineralized by
acetic acid and was used as a positive control.
Addition of the recombinant growth factors IGF1,
TGFb2 or OP1 to perichondrium cultures in the pres-
ence of 10% FCS, did not improve incidence nor amount
of cartilage formation (Table 2). Since we could not
demonstrate a di⁄erence between continuous or pulsed
addition of growth factors, these two conditions were
combined in the results. Serum free cultures to which
a combination of IGF1 and TGFb2 was added for three
weeks did not result in stimulation of chondrogenesis.
The use of DBM in perichondrium cultures did not
change the incidence nor the amount of cartilage forma-
tion after 3 weeks (Table 2). Besides induction of cartilage
in the explants, colonization of the DBM by cells was
observed (Fig 6). These cells had a round shape and
a halo of matrix that stained positively with Alcian Blue.
Immunohistochemistry for collagen type II was not feas-
ible on these sections because the DBM did not remain
attached to the slide surface during the staining proce-
dure. The variability in the results with DBM were
thought to be partly due to variable adhesion of
perichondrium tissue to DBM. Attempts were made to
advance the adhesion by soaking the DBM in
autologous blood before it was wrapped in the perichon-
drium. This, however, did not inßuence incidence nor
amount of cartilage formation.
In vivo studies have demonstrated that resorption of
DBM is performed mainly by macrophages. In vitro
macrophages seeded in DBM did not result in visible
resorption of the DBM in 3 weeks. Also it did not
increase cartilage formation. Combination of blood and
macrophages could not mimic the in vivo situation. Since
adhesion and activity of the macrophages was question-
able, DBM was implanted subcutaneously in the ear for
6 days before culturing with or without perichondrium
in vitro. As described in the in vivo experiments, after
6 days subcutaneous implantation, macrophages, mesen-
chymal cells and some Þbrous tissue were present in the
DBM but at this point cartilage formation was still
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Fig. 5. Chondrogenesis in perichondrium in vitro after 3 weeks, show-
ing the variation in results: (a) no chondrogenesis; (b) a few chon-
drogenic cells (indicated with arrows); (c) more extensive cartilage
formation. Original magniÞcation 200].
absent. Then this DBM was cultured for 3 weeks with
or without a perichondrial envelope, and cartilage
formation could be observed in the DBM, however, it
was independent of the presence or absence of
a perichondrial envelope. Visible resorption of DBM
after 6 days in vivo implantation was not observed after
3 weeks of culture.
Table 2
Incidence of chondrogenesis and amount of cartilage formation in vitro
in perichondrium after 3 weeks of culture under various conditions. The
amount of cartilage formation was quantiÞed using image analysis in
the samples where chondrogenesis was present and is presented as % of
the total area of the explant. No statistically signiÞcant di⁄erences were
found
Experimental condition Incidence % Area cartilage
Median Range
Control (10% FCS) 16/66 9 0—32
TGF-b2 4/17 23 6—53
OP1 2/16 6 0—11
IGF1 1/15 2 n.a.
Serum free with IGF1 and TGFb2 0/15 n.a. n.a.
DBM 13/47 6 1—40
DBM#macrophages 1/10 3 n.a.
DBM#blood 6/14 10 1—47
DBM#macrophages#blood 2/10 39 15—62
DBM colonized in vivo 2/5 4 1—6
DBM (colonized in vivo) without
perichondrium 1/5 n.a. n.a.
n.a.: not available.
Fig. 6. Cells colonizing the DBM in vitro after 3 weeks. Note the round
cell shape and the Alcian Blue staining pericellular matrix. The asterisks
indicate the chondrogenic cells, the thick arrow indicate a group of
Þbroblast-like cells. Original magniÞcation 400].
4. Discussion
In the literature cortical DBM has been demonstrated
to contain growth factors which are held responsible for
the chondro- and osteogenic potential of this matrix
[9, 10]. The trabecular bovine DBM we used in this
study, showed only a faint staining for growth factors.
Although in earlier studies addition of growth factors
in vitro was demonstrated to induce chondrogenesis in
periost [11—16], we could not conÞrm this for perichon-
drium; the addition of IGF1, TGFb2 or OP1 in vitro did
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not improve chondrogenesis. The di⁄erence between
perichondrium and periost or the variability in composi-
tion of the serum, might explain this discrepancy in
results. Yaeger et al. [17] showed that addition of IGF-1
and TGF-b2, to cultures in serum-free medium could
induce redi⁄erentiation of human articular chondrocytes
which had lost their phenotype by culturing in mono-
layer. Even this combination of IGF-1 and TGF-b2
however, did not stimulate cartilage formation from rab-
bit ear perichondrium.
So this study does not provide evidence for a role of
growth factors from the DBM for chondrogenesis. The
physical properties of trabecular DBM may be of more
importance. Although the present study showed that
neither the incidence nor the amount of cartilage gener-
ated in vitro was stimulated by the use of DBM, coloniza-
tion of the DBM by cells could be observed. These cells
survived in culture and even had a round shape and
produced an Alcian Blue positive matrix, indicating vi-
able cartilage-like cells. This suggests that DBM acts
more as a scavenger for chondrogenic cells.
In vivo, resorption of DBM seems to be performed
mainly by macrophages. Peritoneal macrophages have
been demonstrated to manifest bone resorption [18].
Murine peritoneal macrophages in culture could absorb
40—50% of small bone particles in two days. In the
present study, peritoneal macrophages were isolated,
seeded in DBM and cultured together with perichon-
drium in vitro. Resorption of DBM was not seen macro-
scopically and contrary to the in vivo situation, DBM
was still present after 3 weeks culture. Holtrop et al. [19]
suggested that interaction of two cell types is needed for
the resorption of bone fragments: one cell type inducing
pre-digestion of the matrix with enzymes, and sub-
sequently the macrophages will be able to phagocytize
the debris. So probably, macrophages alone are not able
to digest such large parts of DBM and addition of en-
zymes in vitro might be needed to optimize the action of
macrophages. Landesman and Reddi [20] reported that
the chondro-osteogenic potential of DBM is initially
enhanced after implantation in vivo and at its highest
point the Þrst 5—7 days in vivo. Therefore, we implanted
DBM in vivo for 6 days to obtain colonization with cells
and a possible pre-digestion of the DBM, before cultur-
ing with perichondrium in vitro for 3 weeks. This com-
bined in vivo/in vitro procedure, however, did not result
in visible better resorption of the DBM nor did it increase
chondrogenesis.
As another important factor in the in vivo process, the
presence of clotted blood in contact with perichondrium
is described to be necessary for cartilage formation [21].
Clotted blood consists of many platelets which contain
growth factors like PDGF and TGFb. Cells of the
perichondrium are described to grow in the blood clot
and form cartilage [22]. However, neither addition of
autologous blood nor addition of blood in combination
with peritoneal macrophages to our cultures resulted in
any stimulation of chondrogenesis.
DBM by itself (without perichondrium) demonstrated
no cartilage formation after 3—6 weeks of subcutaneous
implantation in vivo. However, culturing in vitro after
6 days of subcutaneous implantation in vivo, chon-
drogenesis was found in one out of Þve samples. This
indicates that cartilage generation in DBM without
perichondrium in principle is possible. Chondrogenic
cells were scavenged by the DBM and these cells could
originate from the skin [23, 24]. Subcutaneous implanta-
tion of DBM without perichondrium for longer periods
(3—6 weeks) never generated cartilage. The reason might
be the early resorption of the matrix before cartilage is
formed. It could be concluded that because of the fast
resorption, pure trabecular bovine DBM is insuƒcient
for cartilage production. Perichondrium is a prerequisite
for fast delivery of large amounts of chondrogenic cells.
Other matrices have been described in combination with
perichondrium [25—27]. When a matrix of collagen, hy-
droxyapatite or polyglycolic acid was used, increased
cartilage formation could be found, however, cartilage
did not or minimally invade the biomaterial pores, but
mainly lined the biomaterial [25—27]. This again suggests
that fast resorption of DBM compared to these other
materials might be an important factor in the process of
cartilage graft formation.
In vivo, the use of a composite graft of perichondrium
and DBM has shown to be a reliable method to generate
new cartilage [6, 7]. Such cartilage formation could not
be mimicked in vitro by addition of IGF1, TGFb2. OP1,
DBM, macrophages or blood. It is suggested that this
trabecular DBM has few chondrogenesis inducing quali-
ties but functions mostly as a spacer for cell ingrowth.
The generation of new cartilage by the proper cells mi-
grating into the ÔspacerÕ together with an optimal period
for resorption of the biomaterial makes DBM an excel-
lent matrix for chondrogenesis in vivo.
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